This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Wenting Tsai
Scientist 3 at Genentech


Wenting Tsai is a Scientist 3 at Genentech in the Department of Antibody Engineering. She received her B.A. in Integrative Biology at University of California, Berkeley, and her Ph.D. in Molecular and Medical Pharmacology at the University of California, Los Angeles. Her current focuses include engineering antibodies and enhanced formats for targeted therapies as well as preclinical immunogenicity assessment.

Agenda Sessions

  • Engineering Proteolysis-targeting Antibodies (PROTABs) to Degrade Cell-surface Proteins